Arş. Gör. ERCAN ADAL
- Yöksis ID 357902
- Researcher ID KCL-3938-2024
- ORCID ID 0000-0002-1688-7326
- Scopus ID
- Scholar ID
- E-posta aercan@mersin.edu.tr
- Dahili Telefon
Birim
ECZACILIK FAKÜLTESİ
ECZACILIK MESLEK BİLİMLERİ BÖLÜMÜ
FARMASÖTİK KİMYA ANABİLİM DALI
ECZACILIK MESLEK BİLİMLERİ BÖLÜMÜ
FARMASÖTİK KİMYA ANABİLİM DALI
ÜAK Temel Alan Bilgisi
Sağlık Bilimleri Temel Alanı
Farmasotik Kimya
Farmasotik Kimya
Son 5 Makale
Exploring bisbenzimidazole-chalcone hybrid compounds: Dual-action as antibacterial agents targeting biofilm formation and E. coli DNA gyrase inhibition
JOURNAL OF MOLECULAR STRUCTURE, vol. 1338, no. 14, pp. 142375– Link 2025
From Deep Learning to the Discovery of Promising VEGFR-2 Inhibitors
CHEMMEDCHEM, vol. 19, no. 16, pp. – Link 2024
JOURNAL OF MOLECULAR STRUCTURE, vol. 1338, no. 14, pp. 142375– Link 2025
From Deep Learning to the Discovery of Promising VEGFR-2 Inhibitors
CHEMMEDCHEM, vol. 19, no. 16, pp. – Link 2024
Son 5 Bildiri
Artıfıcıal Intellıgence, Synthesıs And Actıvıty Studıes Of Benzımıdazole-chalcone Compounds For Candıda Albıcans
International Multidisciplinary Symposium on Drug Research and Development - DRD 2023 (04.05.2023 - ) Link 2023
New Bisbenzimidazole-Chalcone Structures; Design, Synthesis, and Docking Studies
10. İlaç Kimyası Kongresi (10.03.2022 - ) Link 2022
Benzimidazole-2-Phenyl with Alkyl / Alkyloxy linker Derivatives: Synthesis and Antiproliferative Evaluation
8th International Congress of Drug Chemistry: Design, Synthesis, Production and Standardization of Pharmaceutical Active Substances (27.02.2020 - 01.03.2020) 2020
International Multidisciplinary Symposium on Drug Research and Development - DRD 2023 (04.05.2023 - ) Link 2023
New Bisbenzimidazole-Chalcone Structures; Design, Synthesis, and Docking Studies
10. İlaç Kimyası Kongresi (10.03.2022 - ) Link 2022
Benzimidazole-2-Phenyl with Alkyl / Alkyloxy linker Derivatives: Synthesis and Antiproliferative Evaluation
8th International Congress of Drug Chemistry: Design, Synthesis, Production and Standardization of Pharmaceutical Active Substances (27.02.2020 - 01.03.2020) 2020